Document is current
Any future updates will be listed below
-
Authors
Escriche-Escuder, Adrian
Trinidad-Fernández, Manuel
Pajares, Bella
Iglesias-Campos, Marcos
Alba, Emilio
Cuesta-Vargas, Antonio I.
Roldán-Jiménez, Cristina
-
Funding
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation (PS16060)
- License Information
-
More Information
Article History
Received: 15 December 2020
Accepted: 12 April 2021
First Online: 23 April 2021
Competing interests
: There is no other relationship with Novartis as partial funder apart from defraying the expenses of employment, and there are no patents, products in development or marketed products relationship to declare according to the definition of financial competing interest given by Scientific Reports.
